drugset / Trial / NCT02245698

Autologous Stem Cell Therapy in Stroke

NCT02245698

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with sub acute/chronic stroke.

Timeline

Start
2008-12
Primary completion
2018-06
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Stem Cell Cell therapy Intrathecal

Indications